Dr. Aasim M. Sheikh, MD

Dr. Sheikh practices at Northwest Atlanta Vascular Care in Marietta, Georgia.

Dr. Sheikh's NPI, 1841249133, was assigned on May 6, 2006. Dr. Sheikh holds Georgia license 57557.

Dr. Sheikh's primary practice is Northwest Atlanta Vascular Care, at 711 Canton Road, Suite 230, Marietta, GA 30060. The practice phone is (404) 554-2196.

Dr. Sheikh's primary practice is Northwest Atlanta Vascular Care in Marietta, Georgia. Dr. Sheikh is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is GI Specialists of Georgia. Dmand AI also links Dr. Sheikh to 5 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheikh practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sheikh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Sheikh is licensed in Georgia.

CMS data shows 874 Medicare services from Dr. Sheikh across 17 procedure codes in 2024, for 342 Medicare patients. Medicare paid $68,636 for them.

CMS counts 342 Medicare patients who saw Dr. Sheikh in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheikh's median patient age at 64, with 57% women.

In 2024, Dr. Sheikh wrote 1,496 Medicare Part D claims for 307 patients. 82% of them were for generic drugs. CMS names the drug for 1,274 of them, across 26 drugs with 11 or more claims each, at $279,671 in total drug cost. In 2023, CMS named 1,158 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sheikh for performance year 2024, reported through an alternative payment model (APM). Dr. Sheikh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Sheikh, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Sheikh, published from 2019 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Double-Blind Method, Liver and Non-alcoholic Fatty Liver Disease. Dr. Sheikh's most frequent co-authors are Stephen H. Caldwell, Kris V. Kowdley, MD and Eric J. Lawitz, MD.

Dmand AI links Dr. Sheikh to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Sheikh that name 4 trials.

CMS Open Payments shows 200 general payments to Dr. Sheikh from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Gilead Sciences, Inc. paid the most, $60,466. It also lists 31 research payments totaling $64,381 from 2016 to 2025, naming 4 clinical trials.